Erytech Pharma SA (DE:2E4A)

Erytech Pharma SA (2E4A) Financial Statements


Erytech Pharma SA Financial Overview

Erytech Pharma SA's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Erytech Pharma SA is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Jun 21
Income Statement-
Total Revenue€ 0.00€ 0.00€ 0.00€ 0.00€ 0.00
Gross Profit-----
EBIT€ 3.10M€ -4.42M€ 14.66M€ -11.68M€ -15.52M
EBITDA€ 3.10M€ -4.42M€ 14.66M€ -11.68M€ -15.52M
Net Income Common Stockholders€ 5.94M€ -5.14M€ 10.89M€ -11.91M€ -16.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 0.00€ 0.00€ 54.35M€ 0.00€ 46.84M
Total Assets--€ 65.99M-€ 83.81M
Total Debt€ 0.00€ 0.00€ 4.01M€ 0.00€ 25.23M
Net Debt€ 0.00€ 0.00€ -50.35M€ 0.00€ -21.61M
Total Liabilities--€ 43.55M-€ 47.45M
Stockholders Equity€ 0.00€ 0.00€ 22.44M€ 0.00€ 36.36M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

Erytech Pharma SA Earnings and Revenue History

Erytech Pharma SA Debt to Assets

Erytech Pharma SA Cash Flow

Erytech Pharma SA Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis